T1	location 871 879	Budapest
T2	eligibility 1170 1286	Patients with primary invasive breast cancer (clinically lymph node negative and less than or equal to 3 cm in size)
T4	total-participants 1965 1969	2106
T7	intervention-participants 2042 2046	1054
T8	control-participants 2088 2092	1052
T9	outcome 2190 2209	Sentinel lymph node
T11	iv-bin-percent 2849 2854	0.82%
T12	cv-bin-percent 2868 2872	1.3%
T13	outcome 2937 2953	overall survival
T10	outcome 2807 2826	axillary recurrence
T5	outcome 2258 2266	positive
T6	total-participants 2434 2437	474
T15	intervention-participants 2448 2451	244
T16	control-participants 2508 2511	230
T17	outcome 2580 2623	mean length of follow-up to the first event
T18	outcome 2632 2662	mean total length of follow-up
T3	intervention 1333 1363	axillary lymph node dissection
T14	control 1394 1420	axillary nodal irradiation
